From the departure of Scott Gottlieb as the US Food and Drug Administration commissioner to a new treatment for sickle cell disease to supersized acquisitions, some of the biggest stories in 2019 set the stage for the new year.
In a presidential election year, the debate around drug prices will continue to figure prominently. Last year, the majority of states across the country enacted laws in attempt to reel in drug prices.
Gene therapy is a hot area of innovation but like all emerging technologies it has seen some setbacks, including a regulatory scandal around one of the first gene therapies to be approved.
This eBook spotlights some of the biggest stories of 2019. If what’s past is prologue, what do these stories say about 2020? It’s just one of several recently added special reports in our library. Click here to read more.
Click here to download the eBook: The Top Biopharma Stories of 2019
Image: Joshua Blake, Getty Images
